Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Feb 15;91(4):1198-205.
doi: 10.1073/pnas.91.4.1198.

Cytokine therapeutics: lessons from interferon alpha

J U Gutterman  1
Affiliations
Review

Cytokine therapeutics: lessons from interferon alpha

J U Gutterman. Proc Natl Acad Sci U S A. .

Abstract

Cytokines are soluble proteins that allow for communication between cells and the external environment. Interferon (IFN) alpha, the first cytokine to be produced by recombinant DNA technology, has emerged as an important regulator of growth and differentiation, affecting cellular communication and signal transduction pathways as well as immunological control. This review focuses on the biological and clinical activities of the cytokine. Originally discovered as an antiviral substance, the efficacy of IFN-alpha in malignant, viral, immunological, angiogenic, inflammatory, and fibrotic diseases suggests a spectrum of interrelated pathophysiologies. The principles learned from in vivo studies will be discussed, particularly hairy cell leukemia, chronic myelogenous leukemia, certain angiogenic diseases, and hepatitis. After the surprising discovery of activity in a rare B-cell neoplasm, IFN-alpha emerged as a prototypic tumor suppressor protein that represses the clinical tumorigenic phenotype in some malignancies capable of differentiation. Regulatory agencies throughout the world have approved IFN-alpha for treatment of 13 malignant and viral disorders. The principles established with this cytokine serve as a paradigm for future development of natural proteins for human disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Treat Res. 1993;62:29-32 - PubMed
    1. Am J Pathol. 1993 Jul;143(1):99-104 - PubMed
    1. N Engl J Med. 1990 May 17;322(20):1430-4 - PubMed
    1. Science. 1993 Sep 24;261(5129):1694-5 - PubMed
    1. Adv Cancer Res. 1993;62:19-64 - PubMed

MeSH terms

Substances

LinkOut - more resources